Diagnostics & Diseases Market Research Reports & Industry Analysis
Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
OpportunityAnalyzer: Ovarian Cancer - Opportunity Analysis and Forecasts to 2025 Summary Ovarian cancer is the fifth most common malignancy in women and is the leading cause of death amongst gynecological cancers ... current treatment options, unmet needs and opportunities, and the drivers and barriers affecting ovarian cancer therapeutics sales in the 7MM. Pipeline analysis ...
May, 2017 280 pagesGlobal Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune ... due to the rapid cell cycle of cancer cells. The key cancer indications of this report are breast, colorectal, lung, and prostate and hematological cancers. A number of common etiologic factors ...
Jun, 2017 420 pages... the market growth. The global blood market is segmented by product, end user, and geography. Based on product, it is divided into whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing ...
Jun, 2017 63 pages... of cancer, rise in healthcare expenditure, increased access to medical insurance, and technological advancements in cancer treatment therapies that fuel the growth of the global cancer immunotherapy market. However, the factors such as lack of awareness about cancer immunotherapy are ...
May, 2017 150 pages... a worldwide overview of the laboratory and POC coagulation testing markets, including estimates of facilities performing coagulation tests, test volume and sales forecasts for coagulation reagents and instruments by country ... provides worldwide test volume estimates for 38 coagulation assays. The report also presents strategic profiles of current and emerging suppliers of coagulation products in terms ...
Jul, 2017 58 pages... coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of coagulation testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U. K. and U. S. Clinical significance and market needs ...
Jul, 2017 302 pages... of leading automated and semiautomated analyzers. The report also presents strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological ...
Jul, 2017 71 pages... of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ... , Valproic Acid, VancomycinDuring the next decade, the TDM market will undergo significant transformation. These changes will be ...
Jul, 2017 313 pages... VPGMarketResearch provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading ... , Immunofixation, Prealbumin, Protein ElectrophoresisDuring the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence ...
Jul, 2017 273 pages... report from VPGMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, ... . The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key ...
Jul, 2017 291 pages... of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles ... future trends in the U. S. , Europe, Japan; provides test volume and sales forecasts by country, market segment and individual test ...
Jul, 2017 297 pages... provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading ... , Testosterone, Thyroglobulin Ab, TPO Ab, TSHDuring the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence ...
Jul, 2017 327 pages... provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading ... Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence ...
Jul, 2017 310 pages... provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading ... , Phencyclidine (PCP), Propoxphene During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence ...
Jul, 2017 318 pages... provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading ... (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence ...
Jul, 2017 300 pages... contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, ... Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers Sales ...
Jul, 2017 366 pages... coagulation testing market ... POC testing., - Comprehensive listings of companies developing or marketing coagulation, testing technologies and products, by assay. Competitive Assessments- Assessments of major suppliers and emerging market ...
Jul, 2017 418 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 568 pages... malignancy assays and the rapid market expansion worldwide. This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany ... test volume and sales forecasts by country and market segment. The report also examines market applications of DNA probes, biochips/microarrays, monoclonal ...
Jul, 2017 257 pages... forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current ... test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies ...
Jul, 2017 240 pages... technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical ...
Jul, 2017 120 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 600 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 563 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 559 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 561 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry , and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 578 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests Review of current instrumentation technologies, and feature comparison ...
Jul, 2017 542 pages... of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares ...
Jul, 2017 80 pages... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers. Technology ...
Jul, 2017 1200 pages... Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product. Geographic Regions France ... Centers Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature comparison ...
Jul, 2017 900 pages... The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in ... should reach $27.4 billion in 2021, with a CAGR of 7.2 %. Surgical and radiation therapy as a segment reached nearly $14.4 billion in 2016 and should reach $20.8 billion ...
Mar, 2017 356 pagesThis cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines.
Nov, 2016 128 pagesThe global clinical laboratory services market is expected to reach USD 327.0 billion by 2025, according to a new report by Grand View Research, Inc. Clinical labs are observed ... Laboratories, Siemens Healthineers, OPKO Health Inc; ARUP Laboratories; Sonic Healthcare; and Neogenomics Laboratories, Inc. Competition amongst the market entities for the development of clinical ...
Jun, 2017 155 pages... pharmacogenomics technology (theranostics and companion diagnostics) market is expected to reach USD 18.3 billion by 2025, according to a new report by Grand View Research, Inc. Diagnostics is coming to grips with the wave of pharmacogenomic ... share of cancer in pharmacogenomics technology market Polymerase Chain Reaction (PCR) was the largest revenue grossing segment of the with respect to technology for theranostics Advantages associated ...
Jun, 2017 150 pages... market for breast cancer mammogram screening. Renub Research study titled “Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast” analyzes the Asia market For Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market ...
Jul, 2017This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and ... strategic profiles of current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know- how, new products ...
Jul, 2017 109 pages... report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ... strategic assessments of current and emerging suppliers of molecular diagnosticsproducts, including their sales, product portfolios, marketing tactics, technological know- how, new products ...
Jul, 2017 180 pages... of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country ...
Jul, 2017 15 pages... for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the ...
Jul, 2017 570 pages... overview of the microbiology testing market environment, structure, size and growth. The report includes estimates of the number of laboratories performing microbiology tests, as well as test volume and sales forecasts by country.The report also presents strategic profiles of leading market players and ...
Jul, 2017 73 pages... for microbiology testing, including their operating characteristics, features and selling prices. The report also presents strategic assessments of leading microbiology market players ...
Jul, 2017 86 pages... and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products. Contains 650 pages and 47 tables
Jul, 2017 650 pages... for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the ...
Jul, 2017 430 pages... for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five ... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the ...
Jul, 2017 408 pages... and business opportunities for instrument and consumable suppliers. Rationale Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among ... tasks for diagnostic companies during the next five years. Spain Market Overview Laboratories performing DNA sequencing and molecular ...
Jul, 2017 407 pages